TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16872308

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol and ascorbic acid (vitamins)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no vitamins)
Number of subjects: 32
Study: 14654605

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (5 mg of elemental zinc as zinc sulfate in vitamin B complex‐based syrup, 1 mL daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (1 mL of vitamin‐based syrup)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 100
Study: 11304647

Group type: EXPERIMENTAL
Intervention: 5 mg intramuscular haloperidol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Active placebo
Number of subjects: 21
Study: 8985531

Group type: EXPERIMENTAL
Intervention: Haemodialysis
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: CAPD
Number of subjects: 259
Study: 1738183

Group type: EXPERIMENTAL
Intervention: 10 mg of isotretinoin daily
Number of subjects: 981

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 981
Study: 3547351

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) 650 mg
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Ibuprofen 100 mg
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 30025537

Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 45

Group type: COMPARATOR
Intervention: Doctors
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 45
Study: 27431041

Group type: EXPERIMENTAL
Intervention: Motivational intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition (educational intervention)
Number of subjects: 40
Study: 24803366

Group type: EXPERIMENTAL
Intervention: VR‐JIT (Virtual Reality Job Interview Training)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 26
Study: 23253481

Group type: EXPERIMENTAL
Intervention: Multidisciplinary Approach to Management of Maternal Asthma (MAMMA©)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 21572016

Group type: EXPERIMENTAL
Intervention: Continuous incremental supine cycling exercise
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Discontinuous incremental supine cycling exercise
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both exercise protocols
Number of subjects: 9
Study: 20031720

Group type: EXPERIMENTAL
Intervention: Small-molecule glycoprotein IIb/IIIa inhibitors (tirofiban or eptifibatide)
Number of subjects: 2138

Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 2138
Study: 16543129

Group type: EXPERIMENTAL
Intervention: Neurons in the medial temporal lobe (MTL) during a learning task
Number of subjects: 0
Study: 12771472

Group type: EXPERIMENTAL
Intervention: Vitamin C iontophoresis
Number of subjects: 29

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 29
Study: 10874265

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 19185

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 19185
Study: 9398932

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 0

Group type: COMPARATOR
Intervention: L-alpha-acetylmethadol (LAAM)
Number of subjects: 0
Study: 1287107

Group type: EXPERIMENTAL
Intervention: Desipramine, 50 mg by mouth
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Intravenous morphine, 0.033 mg/kg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Intravenous morphine, 0.10 mg/kg
Number of subjects: 62
Study: 3907989

Group type: EXPERIMENTAL
Intervention: Pirprofen (400 mg twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indomethacin (50 mg twice daily)
Number of subjects: 30
Study: 30955403

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS to left primary motor cortex (Group M1, n=10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS to left dorsolateral prefrontal cortex (Group DLPFC, n=10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS (Group sham, n=10)
Number of subjects: 30
Study: 29936726

Group type: EXPERIMENTAL
Intervention: FOCUS program family-based intervention (6 sessions covering family involvement, optimism, cancer coping, uncertainty reduction, symptom management)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 27464793

Group type: EXPERIMENTAL
Intervention: Resistance training (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Passive physical therapy (group B)
Number of subjects: 60
Study: 25056569

Group type: EXPERIMENTAL
Intervention: Broad-spectrum micronutrient treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 22341632

Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate (PVP) with GreenLight HPS 120-W laser
Number of subjects: 139

Group type: COMPARATOR
Intervention: Monopolar transurethral resection of the prostate (TURP)
Number of subjects: 139
Study: 20657097

Group type: EXPERIMENTAL
Intervention: Dental health education (DHE) conducted every three weeks
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Dental health education (DHE) conducted every six weeks
Number of subjects: 415

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 415
Study: 18572041

Group type: EXPERIMENTAL
Intervention: TLC diet with 0.5 cups of soy nuts (25 g soy protein and 101 mg aglycone isoflavones)
Number of subjects: 60

Group type: COMPARATOR
Intervention: TLC diet alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TLC diet with soy nuts
Number of subjects: 60
Study: 16093734

Group type: EXPERIMENTAL
Intervention: High walnut diet (20 energy%)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: High cashew diet (20 energy%)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 68
Study: 11879257

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Antacid (30-ml dose of magnesium hydroxide/aluminium hydroxide)
Number of subjects: 34
Study: 10999119

Group type: EXPERIMENTAL
Intervention: TRH study in Group 1 (29 patients) with normal TSH response to TRH
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TRH study in Group 2 (20 patients) with normal baseline TSH and exaggerated TSH response to TRH
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TRH study in Group 3 (18 patients) with baseline TSH 5 to 10 mu IU/ml and exaggerated TSH response to TRH
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (11 subjects)
Number of subjects: 82
Study: 7743572

Group type: EXPERIMENTAL
Intervention: Atracurium (225 micrograms.kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mivacurium (65 micrograms.kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rocuronium (300 micrograms.kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vecuronium (40 micrograms.kg‐1)
Number of subjects: 0
Study: 2139387

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6113074

Group type: EXPERIMENTAL
Intervention: Clobazam (30 to 80 mg/day)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Diazepam (15 to 40 mg/day)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 31764972

Group type: EXPERIMENTAL
Intervention: T2 ratio
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: %LGE
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: SAnCtUS score (score = 4)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined endpoint (sustained ventricular tachycardia and sudden cardiac death)
Number of subjects: 150
Study: 31102650

Group type: EXPERIMENTAL
Intervention: Buccal film containing microdoses of midazolam (30 μg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Buccal solution of midazolam
Number of subjects: 12
Study: 28683981

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 26495770

Group type: EXPERIMENTAL
Intervention: Slow titration of sertraline
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Regular titration of sertraline
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 23756309

Group type: EXPERIMENTAL
Intervention: Psychoeducational videotaped message (intervention group)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Brochure (control group)
Number of subjects: 415
Study: 21978770

Group type: EXPERIMENTAL
Intervention: Trial protein substitute (TPS) with a carbohydrate/protein-equivalent ratio of 0.5:1
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control protein substitute (CPS) with a carbohydrate/protein-equivalent ratio of 1:1
Number of subjects: 14
Study: 19050625

Group type: EXPERIMENTAL
Intervention: Attendance by a rapid response system team or cardiac arrest team
Number of subjects: 741744
Study: 16534036

Group type: EXPERIMENTAL
Intervention: Feedback on performance
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Feedback plus reminders
Number of subjects: 345

Group type: COMPARATOR
Intervention: Reminders alone
Number of subjects: 345

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 345
Study: 12724111

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 11023139

Group type: EXPERIMENTAL
Intervention: linoleic acid diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: oleic acid diet
Number of subjects: 11
Study: 9279219

Group type: EXPERIMENTAL
Intervention: Nebulized glutathione (GSH) 600 mg with 4 ml of 0.9% sodium chloride
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (identical saline solution)
Number of subjects: 8
Study: 8286805

Group type: EXPERIMENTAL
Intervention: Clindamycin 2% vaginal cream
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 215
Study: 3268179

Group type: EXPERIMENTAL
Intervention: Morphine (0.1 mg/Kg)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Meperidine (1.5 mg/Kg)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Mixture of morphine and meperidine
Number of subjects: 180
Study: 29482033

Group type: EXPERIMENTAL
Intervention: CBT + BA + CM
Number of subjects: 92

Group type: COMPARATOR
Intervention: CBT + BA
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Cotinine
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: In-treatment cotinine decreases
Number of subjects: 92
Study: 27185681

Group type: EXPERIMENTAL
Intervention: Video‐Mac VL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: GlideScope VL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: McGrath VL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All three VL devices
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Video‐Mac VL and McGrath VL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Video‐Mac VL and GlideScope VL
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard Direct Laryngoscopy (DL)
Number of subjects: 121
Study: 25149616

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 241

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Both laparoscopic and open appendectomy
Number of subjects: 241
Study: 23824727

Group type: EXPERIMENTAL
Intervention: RBC 20:1n-9
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: RBC 22:1n-9
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: RBC cis 18:1n-9
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: RBC 24:1n-9
Number of subjects: 2000
Study: 21162515

Group type: EXPERIMENTAL
Intervention: Tension band wire
Number of subjects: 65

Group type: COMPARATOR
Intervention: Hook plate
Number of subjects: 65
Study: 20467650

Group type: EXPERIMENTAL
Intervention: Immediately loaded implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Early loaded implants
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 15302735

Group type: EXPERIMENTAL
Intervention: Aggressive LDL cholesterol lowering
Number of subjects: 852

Group type: COMPARATOR
Intervention: Moderate LDL cholesterol lowering
Number of subjects: 852

Group type: EXPERIMENTAL
Intervention: Low-dose warfarin
Number of subjects: 852

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 852
Study: 11239659

Group type: EXPERIMENTAL
Intervention: Digoxin (1 mg) injected intra-amniotically 24 hours before the procedure
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (saline) injected intra-amniotically 24 hours before the procedure
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Digoxin (1 mg)
Number of subjects: 126
Study: 9663724

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (RBC) 400 mg b.d. for 28 days plus clarithromycin 500 mg b.d. for 7 days (Group A)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (RBC) 400 mg b.d. for 28 days plus clarithromycin 500 mg b.d. for 14 days (Group B)
Number of subjects: 112
Study: 7819689

Group type: EXPERIMENTAL
Intervention: Steroids only (14 patients, 63.6%)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Steroids and high-dose gamma globulin (4 patients)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Steroids and splenectomy (2 patients)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Steroids and immunosuppressive therapy (2 patients)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Initial prednisone course (1-5 mg/kg/day)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: No treatment (4 patients, 18.2%)
Number of subjects: 92
Study: 2978324

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg/day
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg/day
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg/day
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg/day
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg/day
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Pizotifen 1.5 mg/day
Number of subjects: 500
Study: 30895678

Group type: EXPERIMENTAL
Intervention: Customized poly-ether-ether-ketone (PEEK) mesh
Number of subjects: 16

Group type: COMPARATOR
Intervention: Prebent titanium mesh (Control group)
Number of subjects: 16
Study: 28285932

Group type: EXPERIMENTAL
Intervention: Calf raise exercise
Number of subjects: 29

Group type: COMPARATOR
Intervention: Walking exercise
Number of subjects: 29
Study: 25561075

Group type: EXPERIMENTAL
Intervention: EMG‐BF (Electromyography Biofeedback) during maximal voluntary isometric contractions (MVICs)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control condition (MVICs without EMG‐BF)
Number of subjects: 15
Study: 22364109

Group type: EXPERIMENTAL
Intervention: Mental contrasting condition (fantasising about positive outcomes of losing weight and contrasting these fantasies with obstacles)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Positive indulging condition (fantasising about positive outcomes of losing weight)
Number of subjects: 64
Study: 21923923

Group type: EXPERIMENTAL
Intervention: Quetiapine (Q)
Number of subjects: 29
Study: 18679165

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (3.4 +/- 1.1 mL/d)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Cow's milk or infant formula (control)
Number of subjects: 83
Study: 17063405

Group type: EXPERIMENTAL
Intervention: Chinese version of Lam Assessment of Stages of Employment Readiness (LASER)
Number of subjects: 90
Study: 12554998

Group type: EXPERIMENTAL
Intervention: Endoscopic lymphadenectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Classic lymphadenectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study: 10867086

Group type: EXPERIMENTAL
Intervention: Modified Protocol (MP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional Protocol (TP)
Number of subjects: 80
Study: 9352964

Group type: EXPERIMENTAL
Intervention: Abciximab bolus and infusion
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Abciximab bolus
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 101
Study: 8245085

Group type: EXPERIMENTAL
Intervention: Operative treatment (n = 25)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conservative treatment (n = 31)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Conservative treatment for undisplaced fractures (n = 10)
Number of subjects: 66
Study: 3545844

Group type: EXPERIMENTAL
Intervention: Amoxicillin twice daily (60 mg/kg per day for 10 days)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Amoxicillin thrice daily (60 mg/kg per day for 10 days)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Amoxicillin twice daily
Number of subjects: 110

Group type: COMPARATOR
Intervention: Amoxicillin thrice daily
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Amoxicillin twice daily and thrice daily
Number of subjects: 110
Study: 30448267

Group type: EXPERIMENTAL
Intervention: Education-plus-values-clarification version of the decision aid
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Education-only version of the decision aid
Number of subjects: 1000
Study: 30794972

Group type: EXPERIMENTAL
Intervention: Dual-layer duraplasty
Number of subjects: 123

Group type: COMPARATOR
Intervention: Single-layer duraplasty
Number of subjects: 123
Study: 29728142

Group type: EXPERIMENTAL
Intervention: Doppler
Number of subjects: 2684

Group type: COMPARATOR
Intervention: Fetoscope
Number of subjects: 2684
Study: 27224235

Group type: EXPERIMENTAL
Intervention: Model-based iterative reconstruction (MBIR)
Number of subjects: 56
Study: 25441408

Group type: EXPERIMENTAL
Intervention: Afatinib (40 mg/day, increasing to 50 mg/day if minimal toxicity)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 loading dose, then 250 mg/m2/week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Afatinib in KRAS-mutated group
Number of subjects: 50
Study: 22507365

Group type: EXPERIMENTAL
Intervention: Interferential laser therapy (n=100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional laser therapy (n=100)
Number of subjects: 200
Study: 20480136

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) for 3 days
Number of subjects: 67

Group type: COMPARATOR
Intervention: Oxygen alone for 3 days
Number of subjects: 67
Study: 17513190

Group type: EXPERIMENTAL
Intervention: Active gel (lidocaine 20 mg/g)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 40
Study: 14967173

Group type: EXPERIMENTAL
Intervention: High intensity exercise (5000 steps at 180 steps/min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Middle intensity exercise (5000 steps at 130 steps/min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low intensity exercise (5000 steps at 80 steps/min)
Number of subjects: 24
Study: 11779600

Group type: EXPERIMENTAL
Intervention: Blastocyst transfer
Number of subjects: 162

Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 162
Study: 9689289

Group type: EXPERIMENTAL
Intervention: 1% aqueous sodium lauryl sulfate (SLS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study: 7863833

Group type: EXPERIMENTAL
Intervention: Alendronate, 20 mg/day for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 30
Study: 2923740

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Mediastinoscopy
Number of subjects: 125
Study: 30989655

Group type: EXPERIMENTAL
Intervention: REBACIN®
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 199
Study: 29119864

Group type: EXPERIMENTAL
Intervention: Having an informal caregiver
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Social support score
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Having an informal caregiver with social support included
Number of subjects: 253
Study: 25256207

Group type: EXPERIMENTAL
Intervention: 3D audiovisual distraction (3D video glasses)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Audio distraction (music)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (basic behaviour guidance techniques without distraction)
Number of subjects: 90
Study: 23257278

Group type: EXPERIMENTAL
Intervention: Reinforcement during learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation based TI task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleep after a 12-hour delay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wake after a 12-hour delay
Number of subjects: 0
Study: 21812261

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Granule (BHG)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Madopar (basic treatment) + BHG
Number of subjects: 94

Group type: COMPARATOR
Intervention: Madopar (basic treatment) + Placebo
Number of subjects: 94
Study: 18521097

Group type: EXPERIMENTAL
Intervention: Cold caloric vestibular stimulation
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo procedures
Number of subjects: 1
Study: 16487224

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 mg daily for 6 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 12966817

Group type: EXPERIMENTAL
Intervention: Manually guided exposure therapy in virtual environments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list condition (control group)
Number of subjects: 0
Study: 16627796

Group type: EXPERIMENTAL
Intervention: Regular red cell transfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Episodic or no transfusion
Number of subjects: 0